EP1 receptor within the ventrolateral periaqueductal grey controls thermonociception and rostral ventromedial medulla cell activity in healthy and neuropathic rat

Molecular Pain

Volumn 7, Issue , 2011, Pages

  Palazzo, Enza ^a   Guida, Francesca ^a   Gatta, Luisa ^a   Luongo, Livio ^a   Boccella, Serena ^a   Bellini, Giulia ^a   Marabese, Ida ^a   de Novellis, Vito ^a   Rossi, Francesca ^a   Maione, Sabatino ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Antinociceptive descending pathway; Ep1 receptor; On and off cell activity; Rat; Spared nerve injury; Tail flick

Indexed keywords

L 335677; ONO DI 004; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG; VESICULAR INHIBITORY AMINO ACID TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; GABAERGIC SYSTEM; MALE; MEDULLA OBLONGATA; NERVE CELL; NERVE FUNCTION; NERVE INJURY; NEUROMODULATION; NEUROPATHIC PAIN; NEUROPATHOLOGY; NOCICEPTION; NONHUMAN; OFF CELL; ON CELL; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR BLOCKING; RECEPTOR OCCUPANCY; ROSTRAL VENTROMEDIAL MEDULLA; SCIATIC NERVE; SIGNAL TRANSDUCTION; TAIL FLICK TEST; THERMONOCICEPTION; VENTROLATERAL PERIAQUEDUCTAL GRAY MATTER;

ACETATES; ALPROSTADIL; ANIMALS; BENZYL COMPOUNDS; DINOPROSTONE; HEALTH; MALE; MEDULLA OBLONGATA; MICROINJECTIONS; NEURALGIA; NOCICEPTION; PERIAQUEDUCTAL GRAY; PROTEIN TRANSPORT; RATS; RATS, WISTAR; REACTION TIME; RECEPTORS, PROSTAGLANDIN E, EP1 SUBTYPE; SCIATIC NERVE; TEMPERATURE;

EID: 80054821338     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-7-82     Document Type: Article

References (44)

1. Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 1998, 38:97-120. 10.1146/annurev.pharmtox.38.1.97, 9597150.
2. Svensson CI, Yaksh TL. The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing. Annu Rev Pharmacol Toxicol 2002, 42:553-83. 10.1146/annurev.pharmtox.42.092401.143905, 11807183.
3. Vanegas H, Schaible HG. Prostaglandins and cyclooxygenases in the spinal cord. Prog Neurobiol 2001, 4:327-63.
4. Heinricher MM, Barbaro NM, Fields HL. Putative nociceptive modulating neurons in the rostral ventromedial medulla of the rat: firing of ON and OFF cells is related to nociceptive responsiveness. Somatosens Mot Res 1989, 6:427-439. 10.3109/08990228909144685, 2547275.
5. Breder CD, Smith WL, Raz A, Masferrer J, Seibert K, Needleman P, Saper CB. Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brain. J Comp Neurol 1992, 322:409-38. 10.1002/cne.903220309, 1517485.
6. Ek M, Arias C, Sawchenko P, Ericsson-Dahlstrand A. Distribution of the EP3 prostaglandin E(2) receptor subtype in the rat brain: relationship to sites of interleukin-1-induced cellular responsiveness. J Comp Neurol 2000, 428:5-20. 10.1002/1096-9861(20001204)428:1<5::AID-CNE2>3.0.CO;2-M, 11058221.
7. Nakamura K, Kaneko T, Yamashita Y, Hasegawa H, Katoh H, Negishi M. Immunohistochemical localization of prostaglandin EP3 receptor in the rat nervous system. J Comp Neurol 2000, 421:543-69. 10.1002/(SICI)1096-9861(20000612)421:4<543::AID-CNE6>3.0.CO;2-3, 10842213.
8. Tortorici V, Vanegas H. Anti-nociception induced by systemic or PAG-microinjected lysine-acetylsalicylate in rats. Effects on tail-flick related activity of medullary off- and on-cells. Eur J Neurosci 1995, 7:1857-65. 10.1111/j.1460-9568.1995.tb00706.x, 8528459.
9. Vanegas H, Tortorici V, Eblen-Zajjur A, Vásquez E. PAG-microinjected dipyrone (metamizol) inhibits responses of spinal dorsal horn neurons to natural noxious stimulation in rats. Brain Res 1997, 759:171-4. 10.1016/S0006-8993(97)00360-0, 9219879.
10. Leith JL, Wilson AW, Donaldson LF, Lumb BM. Cyclooxygenase-1-derived prostaglandins in the periaqueductal gray differentially control C- versus A-fiber-evoked spinal nociception. J Neurosci 2007, 27:11296-305. 10.1523/JNEUROSCI.2586-07.2007, 17942724.
11. Heinricher MM, Martenson ME, Neubert MJ. Prostaglandin E2 in the midbrain periaqueductal gray produces hyperalgesia and activates pain-modulating circuitry in the rostral ventromedial medulla. Pain 2004, 110:419-26. 10.1016/j.pain.2004.04.026, 15275794.
12. Oliva P, Berrino L, de Novellis V, Palazzo E, Marabese I, Siniscalco D, Scafuro M, Mariani L, Rossi F, Maione S. Role of periaqueductal grey prostaglandin receptors in formalin-induced hyperalgesia. Eur J Pharmacol 2006, 530:40-7. 10.1016/j.ejphar.2005.11.025, 16360148.
13. Ma W, Eisenach JC. Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain. Eur J Neurosci 2002, 15:1037-47. 10.1046/j.1460-9568.2002.01940.x, 11918652.
14. Ma W, Eisenach JC. Four PGE2 EP receptors are up-regulated in injured nerve following partial sciatic nerve ligation. Exp Neurol 2003, 183:581-92. 10.1016/S0014-4886(03)00182-1, 14552899.
15. Ma W, Chabot JG, Vercauteren F, Quirion R. Injured nerve-derived COX2/PGE2 contributes to the maintenance of neuropathic pain in aged rats. Neurobiol Aging 2010, 31:1227-37. 10.1016/j.neurobiolaging.2008.08.002, 18786748.
16. Woodhams PL, MacDonald RE, Collins SD, Chessell IP, Day NC. Localisation and modulation of prostanoid receptors EP1 and EP4 in the rat chronic constriction injury model of neuropathic pain. Eur J Pain 2007, 11:605-13. 10.1016/j.ejpain.2006.09.005, 17110143.
17. Kawahara H, Sakamoto A, Takeda S, Onodera H, Imaki J, Ogawa R. A prostaglandin E2 receptor subtype EP1 receptor antagonist (ONO-8711) reduces hyperalgesia, allodynia, and c-fos gene expression in rats with chronic nerve constriction. Anesth Analg 2001, 93:1012-7. 10.1097/00000539-200110000-00043, 11574375.
18. Asbóth G, Phaneuf S, Europe-Finner GN, Tóth M, Bernal AL. Prostaglandin E2 activates phospholipase C and elevates intracellular calcium in cultured myometrial cells: involvement of EP1 and EP3 receptor subtypes. Endocrinology 1996, 137:2572-9. 10.1210/en.137.6.2572, 8641211.
19. Decosterd I, Woolf CJ. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 2000, 87(2):149-58. 10.1016/S0304-3959(00)00276-1, 10924808.
20. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. Academic Press 1986, London.
21. Fields HL, Bry J, Hentall I, Zorman G. The activity of neurons in the rostral medulla of the rat during withdrawal from noxious heart. J Neurosci 1983, 3:2545-2552.
22. Yamamoto H, Maruyama T, Sakata K, Koketsu M, Kobayashi M, Yoshida H, Seki A, Tani K, Maruyama T, Kondo K, Ohuchida S. Novel four selective agonists for prostaglandin E receptor subtypes. Prostaglandins Other Lipid Mediat 1999, 59:150.
23. Ducharme Y, Blouin M, Carrière MC, Chateauneuf A, Côté B, Denis D, Frenette R, Greig G, Kargman S, Lamontagne S, Martins E, Nantel F, O'Neill G, Sawyer N, Metters KM, Friesen RW. 2, 3-Diarylthiophenes as selective EP1 receptor antagonists. Bioorg Med Chem Lett 2005, 15:1155-60. 10.1016/j.bmcl.2004.12.005, 15686932.
24. Palazzo E, Marabese I, Soukupova M, Luongo L, Boccella S, Giordano C, de Novellis V, Rossi F, Maione S. Metabotropic glutamate receptor subtype 8 in the amygdala modulates thermal threshold, neurotransmitter release, and rostral ventromedial medulla cell activity in inflammatory pain. J Neurosci 2011, 31(12):4687-97. 10.1523/JNEUROSCI.2938-10.2011, 21430167.
25. Minami T, Nakano H, Kobayashi T, Sugimoto Y, Ushikubi F, Ichikawa A, Narumiya S, Ito S. Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice. Br J Pharmacol 2001, 133:438-44. 10.1038/sj.bjp.0704092, 1572799, 11375261.
26. Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, Bonventre JV, Woolf CJ. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001, 410:471-5. 10.1038/35068566, 11260714.
27. Svensson CI, Yaksh TL. The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing. Annu Rev Pharmacol Toxicol 2002, 42:553-83. 10.1146/annurev.pharmtox.42.092401.143905, 11807183.
28. Oertel WH, Mugnaini E. Immunocytochemical studies of GABAergic neurons in rat basal ganglia and their relations to other neuronal systems. Neuroscience Letters 1984, 47:233-8. 10.1016/0304-3940(84)90519-6, 6147799.
29. Reichling DB, Basbaum AI. Collateralization of periaqueductal gray neurons to forebrain or diencephalon and to the medullary nucleus raphe magnus in the rat. Neuroscience 1991, 42:183-200. 10.1016/0306-4522(91)90158-K, 1713655.
30. Tanaka Y, Furuyashiki T, Momiyama T, Namba H, Mizoguchi A, Mitsumori T, Kayahara T, Shichi H, Kimura K, Matsuoka T, Nawa H, Narumiya S. Prostaglandin E receptor EP1 enhances GABA-mediated inhibition of dopaminergic neurons in the substantia nigra pars compacta and regulates dopamine level in the dorsal striatum. Eur J Neurosci 2009, 30:2338-46. 10.1111/j.1460-9568.2009.07021.x, 20092576.
31. Lu J, Xing J, Li J. Prostaglandin E2 (PGE2) inhibits glutamatergic synaptic transmission in dorsolateral periaqueductal gray (dl-PAG). Brain Res 2007, 1162:38-47. 2030489, 17612511.
32. Southall MD, Bolyard LA, Vasko MR. Twenty-four hour exposure to prostaglandin downregulates prostanoid receptor binding but does not alter PGE(2)-mediated sensitization of rat sensory neurons. Pain 2002, 96(3):285-96. 10.1016/S0304-3959(01)00458-4, 11973001.
33. Donaldson LF, Humphrey PS, Oldfield S, Giblett S, Grubb BD. Expression and regulation of prostaglandin E receptor subtype mRNAs in rat sensory ganglia and spinal cord in response to peripheral inflammation. Prostaglandins Other Lipid Mediat 2001, 63(3):109-122. 10.1016/S0090-6980(00)00101-5, 11204738.
34. Beiche F, Scheuerer S, Brune K, Geisslinger G, Goppelt-Struebe M. Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett 1996, 390(2):165-9. 10.1016/0014-5793(96)00604-7, 8706851.
35. Hay CH, Trevethick MA, Wheeldon A, Bowers JS, de Belleroche JS. The potential role of spinal cord cyclooxygenase-2 in the development of Freund's complete adjuvant-induced changes in hyperalgesia and allodynia. Neuroscience 1997, 78(3):843-50. 10.1016/S0306-4522(96)00598-2, 9153662.
36. Coleman RA, Grix SP, Head SA, Louttit JB, Mallett A, Sheldrick RL. A novel inhibitory prostanoid receptor in piglet saphenous vein. Prostaglandins 1994, 47:151-68. 10.1016/0090-6980(94)90084-1, 8016385.
37. Pertovaara A. Plasticity in descending pain modulatory systems. Prog Brain Res 2000, 129:231-42.
38. Porreca F, Burgess SE, Gardell LR, Vanderah TW, Malan TP, Ossipov MH, Lappi DA, Lai J. Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor. J Neurosci 2001, 21:5281-8.
39. Porreca F, Ossipov MH, Gebhart GF. Chronic pain and medullary descending facilitation. Trends Neurosci 2002, 25:319-25. 10.1016/S0166-2236(02)02157-4, 12086751.
40. Ossipov MH, Porreca F. Descending excitatory systems. Chapter 14 Handb Clin Neurol 2006, 81:193-210.
41. Gonçalves L, Almeida A, Pertovaara A. Pronociceptive changes in response properties of rostroventromedial medullary neurons in a rat model of peripheral neuropathy. Eur J Neurosci 2007, 26:2188-95. 10.1111/j.1460-9568.2007.05832.x, 17892482.
42. Syriatowicz JP, Hu D, Walker JS, Tracey DJ. Hyperalgesia due to nerve injury: role of prostaglandins. Neuroscience 1999, 94:587-94. 10.1016/S0306-4522(99)00365-6, 10579219.
43. Bee LA, Dickenson AH. Rostral ventromedial medulla control of spinal sensory processing in normal and pathophysiological states. Neuroscience 2007, 147:786-93. 10.1016/j.neuroscience.2007.05.004, 17570596.
44. Heinricher MM, Tavares I, Leith JL, Lumb BM. Descending control of nociception: Specificity, recruitment and plasticity. Brain Res Rev 2009, 60:214-25. 10.1016/j.brainresrev.2008.12.009, 2894733, 19146877.